Table 1:
Patients (n = 33) | |
---|---|
Age (yr) (mean) (SD) | 68 (16) |
Male (%) | 14 (42.4) |
Hypertension (%) | 21 (63.6) |
Diabetes mellitus (%) | 4 (12.1) |
Atrial fibrillation (%) | 13 (39.4) |
Coronary artery disease (%) | 7 (21.2) |
Congestive heart failure (%) | 3 (9.1) |
Hypercholesterolemia (%) | 8 (24.2) |
Previous stroke (%) | 0 |
History of smoking (%) | 8 (24.2) |
Prestroke mRS | |
0 (%) | 28 (84.8) |
1 (%) | 2 (6.1) |
2 (%) | 1 (3) |
3 (%) | 2 (6.1) |
Initial NIHSS score (median) (IQR) | 5 (4–7) |
CT | n = 18 |
MR imaging | n = 15 |
ASPECTSa (median) (IQR) | |
CT | 10 (9–10) |
MR imaging | 8 (7–9)b |
Time from stroke onset to imaging (min) (median) (IQR) | 175 (72–279) |
Intravenous tPA (%) | 22 (66.7) |
Time from stroke onset to intravenous tPAc (min) (median) (IQR) | 156 (94–238) |
Time from stroke onset to groin puncture (min) (median) (IQR) | 320 (237–528) |
Occlusion site | |
ICA (excluding carotid T) (%) | 4 (12.1) |
Tandem occlusion (cervical ICA and carotid T/M1) | 3 (9.1) |
Carotid T (%) | 2 (6.1) |
M1 (%) | 17 (51.5) |
M2 (%) | 7 (21.2) |
Collateral status | |
0 (%) | 0 |
1 (%) | 2 (6.1) |
2 (%) | 7 (21.2) |
3 (%) | 24 (72.7) |
Thrombus length (mm) | 12 (10–16) |
According to modality.
MR-ASPECTS assessed on axial diffusion-weighted images.
For patients eligible for intravenous thrombolysis.